Clinical trial · Interventional
Develop and Evaluate An Artificial Intelligence Assisted Prehabilitation Program for Returning to Work and Cost-effectiveness Analysis in Patients With Oral Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this clinical trial is to develop and evaluate an Artificial Intelligence Assisted Prehabilitation Program (AI APP) for returning to work and cost-effectiveness analysis in patients with oral cancer (OC). The main questions it aims to answer are: * What kinds of needs are related to returning to work (RTW) in patients with OC from diagnosis to survival that we can incorporate into the development of AI APP to assist this population ? * How is the effect of the AI APP that based on findings from the first question for patients with OC on physical and psychological distress, fear of recurrence, self-efficacy in coping with cancer, communication, motor function, quality of life, and RTW? * How is the effect of the RTW AI prediction model to identify high-risk groups ? And how is the comprehensive cost effectiveness of benefits and quality of life of the AI APP for OC population? Researchers will compare patients without using AI APP to see if the AI APP works to assist with coping physical and psychological distress, communication, motor function, quality of life, and RTW issues for individuals with OC? Participants will: * Be asked to fulfill a structural questionnaire, or engage in a semi-structured one-by-one interview or a focus group to assess their physical, psychological, and social support needs in the first stage. * Be invited to participant the pilot testing of AI APP in the second stage. * Be provided and trained by 3-month AI APP for 3 months or cared as usual in the third stage. * Complete a structural questionnaire and follow up one year, including the baseline (before using the AI app) and at 1-2 weeks, 3 months, 6 months, 9 months, and 12 months after the baseline. * Engage in one-by-one interview or a focus group to assess user experiences of the AI APP.
Conditions
Conditions (14)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Artifical Intelligence | — | UNRESOLVED | — |
| Case Management, APP(Application) | — | UNRESOLVED | — |
| Communication Aids for Disabled | — | UNRESOLVED | — |
| Cost Effectiveness | — | UNRESOLVED | — |
| Motor Function | — | UNRESOLVED | — |
| Oral Cancer | Malignant Lip and Oral Cavity Neoplasm | CURATED_BROADER | 0.80 |
| Physical Symptom Distress | — | UNRESOLVED | — |
| Physiotherapy | — | UNRESOLVED | — |
| Prediction Model | — | UNRESOLVED |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| AI-based physiotherapy | Behavioral | — | UNRESOLVED |
| Conventional physiotherapy | Behavioral | — | UNRESOLVED |
| Prehabilitation application | Device | — | UNRESOLVED |
| Scar management | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Control group Usual care
- description
- The patients in this group will not use the AI APP. They will receive 12 times of physiotherapy and keep receiving usual care.
- interventionNames
- Behavioral: Conventional physiotherapy
- Behavioral: Scar management
- type
- EXPERIMENTAL
- label
- Intervention group
- description
- The patients in this group will receive and use AI APP while receiving usual care.
- interventionNames
- Device: Prehabilitation application
- Behavioral: Scar management
- Behavioral: AI-based physiotherapy
Primary outcomes (11)
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Adult (\> 20 years old and younger than 70 years old) * Newly diagnosed as OC and scheduled to receive cancer-related treatment * Able to use Mobile phone * Willing to sign an informed consent form after receiving a detailed explanation of the study's aims and procedures * Healthcare professionals involved in patients' care, including doctors, nurses, case managers, dietitians, rehabilitation therapists, and psychologists * Family members who are primary caregivers of the participating patients, engaged in different stages of medical care Exclusion Criteria: * Risk populations for walking or performing exercise * Patients with cognitive impairment or psychiatric diseases
References
Publications (0)
Data not yet available